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The incorporation of two fluorine-containing general anesthetic agents, halothane and methoxyflurane, 
into erythrocytes (from three different species), rabbit muscle and rabbit nerve, was followed with 19F 
NMR spectroscopy. Two major findings emerged from these studies: (1) multiple environments indicative 
of domain structure in the membrane can be observed depending on the anesthetic and the tissue type; 
and (2) the 19F chemical shifts of a given anesthetic were characteristic for the tissue examined. Halothane 
showed a single resonance in erythrocytes and multiple resonances in muscle and nerve, while 
methoxyflurane showed multiple resonances in both muscle and erythrocytes. The range of the 19F 
chemical shifts for the multiple peaks was as great as 6 ppm. 
Halothane Methoxyflurane Nerve Muscle Erythrocyte NMR 
1. INTRODUCTION 
Even though general anesthetics have been used 
for over a hundred years, the mechanism of action 
of these agents is still actively debated. The site at 
which general anesthetics act is widely believed to 
be the plasma membrane of the brain cells. 
Disagreements exist about the details of interaction 
at the molecular level, with both membrane-bound 
proteins and the lipid bilayer being suggested as the 
principal locus of action. These and other view- 
points have been presented in two recent reviews 
11921. 
Some of the conflicting opinions appear to arise 
from the fact that only indirect methods have been 
available for the study of membrane-anesthetic in- 
teractions. Model systems such as phospholipid 
vesicles and bilayers [3-71 have often been studied. 
As they are made more realistic and thus more 
complex (e.g., by adding different proteins), the 
ability to get unambiguous experimental results 
diminishes. On the other hand, studies on intact or 
in vivo systems are necessary for the description of 
these membranes in the living state. Unfortunate- 
ly, they are limited in intact animals to such 
physiological measurements as righting behavior 
and other reflex reactions which provide only 
crude and indirect assessment of the biochemistry 
of anesthetic action [8,9]. 
A new methodological approach to this problem 
can be gained by applying 19F nuclear magnetic 
resonance spectroscopy. Fluorine-19 offers distinct 
advantages over other nuclei: “F-containing 
anesthetics can serve as their own probes, the sen- 
sitivity for 19F detection is high, and no interfering 
fluorine compounds exist naturally in tissue. With 
these considerations in mind, we have initiated a 
study of fluorinated anesthetics in intact tissues in 
order to characterize the microenvironment(s) 
within which anesthetics act. If various microen- 
vironments can be distinguished with the aid of 
these anesthetics, this technique should have im- 
portant applications in the general area of mem- 
brane analysis as well as in the more specific area 
of anesthesia research. 
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2. MATERIALS AND METHODS 
Whole blood was examined either in vitro or in 
vivo. In vitro examination was performed on 
samples collected in heparinized syringes from 
three mammalian species: man, dog, and rabbit. 
The in vivo sampling was achieved by using an 
arterio-venous shunt external to the anesthetized 
dog. An NMR tube was installed in this shunt so 
that it could be placed in the NMR spectrometer 
while the dog pumped the blood through the exter- 
nal circuit [lo]. This allowed direct observation of 
the fluorinated anesthetics while the blood was in 
contact with the body. In order to assign the 19F 
signals observed in whole blood, the major com- 
ponents of blood were examined individually. 
Erythrocytes were separated from plasma by low 
speed centrifugation (3000 x g) and washed with 
20 mM phosphate-buffered (pH 7.4) saline. 
Two examples of excitable tissues which may in- 
teract with anesthetics in a manner analogous to 
the nerve cells in the brain were also examined. The 
sciatic nerve and soleus muscle were removed from 
New Zealand White rabbits and stored in cold, 
well oxygenated Krebs-Ringer bicarbonate buffer 
(pH 7.4) until they were used. 
The anesthetic was delivered to the animal, or to 
the isolated systems, with standard anesthesia 
equipment. A North American Drager-Narcovet 
machine was used along with a semi-closed 
rebreathing system for the delivery of halothane. 
Methoxyflurane levels were regulated with a 
Hidenbrink number 8 vaporizer. 
19F NMR measurements were performed on a 
Bruker WP-80 NMR spectrometer at ambient 
temperature (30°C). The following acquisition 
parameters were used: 2500 Hz sweep width, 90” 
pulse angle and 1.6 s repetition time. Spectra were 
collected without proton decoupling. Chemical 
shifts were measured with respect to a neat 
trifluoroacetic acid (TFA) external standard. 
3. RESULTS 
i9F NMR spectra of methoxyflurane 
(CHsO-CFzCH2Cl) equilibrated in vitro with 
blood display multiple peaks as shown in fig.1. 
The chemical shifts of the resonances observed for 
each of the blood samples examined are summariz- 
ed in table 1. Their ranges are 3.5 ppm for human, 
Fig. 1. 19F NMR spectra of methoxyflurane in (A) rabbit, 
(B) dog and (C) human blood. 
Table 1 
19F chemical shifts of signals from methoxyflurane in 
blood of three mammalian species 
Species Blood Erythrocytes Plasma 
(6, ppmY (6, ppm)’ (8, ppm)’ 
Human -5.0 - 5.0 
- 6.8b -6.8b 
-7.3 -7.3 
-8.5 -8.5 
Dog -4.2 -4.2 
-6.1b -6.1b 
-7.0 -7.0 
-7.3 -7.3 
-9.0 -9.0 
Rabbit -4.4 -4.4 
- 6.0b -6.0 
-7.2 -7.2 
-8.5 -8.5 
- 10.2 - 10.2 
a Chemical shifts are reported as parts per million from 
neat trifluoroacetic acid; positive numbers indicate 
downfield direction 
b Major peak 
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4.8 ppm for dog, and 5.8 ppm for rabbit blood. 
The signals at -7.3 ppm (human and dog blood) 
and at -7.2 ppm (rabbit blood) with 12-15 Hz 
line widths can be assigned to methoxyflurane in 
plasma by comparison with the corresponding 
plasma fraction. Examination of packed red cells 
verifies that the remaining signals arise from 
methoxyflurane distributed in erythrocytes. The 
appearance of multiple peaks suggests slow ex- 
change (in the ms-range) of methoxyflurane bet- 
ween plasma and the different compartments of 
erythrocytes. The line widths of these peaks range 
between 60-200 Hz as a result of differences in 
correlation times which arise from variations in the 
constraints on motion of the ‘bound’ anesthetic. 
As a result of this broadening, the ‘H-r9F coupl- 
ing (which is in the order of 5-6 Hz) cannot be 
observed in any of the spectra reported. 
In contrast to methoxyflurane, halothane 
(CFjCHBrCl) shows only two signals in blood 
from each of the three species examined (table 2). 
There is slow exchange of halothane between 
plasma and the erythrocytes, but there is no 
evidence for multiple environments for halothane 
in the erythrocytes. Line widths for halothane in 
erythrocytes are 80 Hz, whereas those for plasma 
are only 12-15 Hz. The signals observed for 
methoxyflurane or halothane with whole blood in 
vivo are identical to those already described for 
drawn blood. 
Fig.2 shows spectra of rabbit soleus muscle 
equilibrated with methoxyflurane (2A) and with 
halothane (2B). Halothane shows peaks at 2.8 and 
Table 2 
19F chemical shifts of halothane in blood of three 
mammalian species 
Species Blood Erythrocytes Plasma 
(8, PpmY (6, PpmY (6, ppWa 
Human 3.4 3.4 
3.0 3.0 
Dog 3.6 3.6 
2.9 2.9 
Rabbit 4.1 4.1 
3.0 3.0 
a Chemical shifts are reported as parts per million from 
neat trifluoroacetic acid; positive numbers indicate 
downfield direction 
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Fig.2. 19F NMR spectra of (A) methoxyflurane and (B) 
halothane in rabbit soleus muscle. 
2.5 ppm (major peak) and methoxyflurane at 
-7.0 and - 8.0 ppm (major peak). Line widths 
are only 15-20 Hz. 
The 19F NMR spectrum of halothane 
equilibrated with rabbit sciatic nerve (fig.3A) 
shows several peaks which span the chemical shift 
JL A 
Fig.3. r9F NMR spectrum of halothane in (A) fresh and 
(B) aged rabbit sciatic nerve. 
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range from 5.0 to - 1.0 ppm, with different line 
widths. As the excised nerve ages, the pattern of 
NMR peaks changes until only one signal is seen at 
2.5 ppm (3B). These signals reported from whole 
tissue originate only from anesthetic incorporated 
in the muscle or nerve, since buffers in which these 
tissues are suspended uring the NMR experiments 
show no “F signals after tissue is removed. 
4. DISCUSSION 
A range of chemical shifts is observed for both 
halothane and methoxyflurane in the tissues ex- 
amined which is comparable to that seen in pure 
solvents (table 3) [11,12]. The chemical shifts 
observed are dependent upon both the anesthetic 
agent and the type of tissue used. 
Variation of chemical shift with tissue type can 
be illustrated with the data for halothane in rabbit 
tissues. In muscle, the major and minor peaks are 
at chemical shifts 2.5 and 2.8 ppm. The nerve has 
a multiplet with at least eight components on a 
broad base over the range 5 to - 1 ppm. In blood, 
the chemical shift is 4.1 ppm for erythrocytes and 
3.0 ppm for plasma. Methoxyflurane shows 
similar variation in chemical shift with tissue type. 
A more detailed analysis is possible for the data 
on blood and its components. Each anesthetic 
shows a single narrow line with a characteristic 
chemical shift when equilibrated with plasma. The 
position of the signal is independent of species. 
This behavior would be consistent with either fast 
exchange of anesthetic among several sites in the 
plasma, or with a single site. 
Table 3 
19F chemical shifts of halothane and methoxyflurane in 
pure solvents 
Solvent Halothane Methoxyflurane 
(6, ppmY (6, ppmY 
Hz0 2.85 - 7.03 
n-Octanol 2.14 - 8.59 
Hexane 1.16 -9.50 
Heptane 1.25 - 9.43 
Neat 1.41 - 8.60 
Methanol 0.67 - 9.75 
a Chemical shifts are reported as parts per million from 
neat trifluoroacetic acid; positive numbers indicate 
downfield direction 
The signals from erythrocytes are species 
specific and consist of 3 or 4 lines for methox- 
yflurane, while halothane gives only single line, 
also species specific (see tables 1 and 2). This dif- 
ference in signal characteristics may be due to the 
different solubilities of these agents in blood [13]; 
methoxyflurane is five times as soluble as 
halothane. We propose that the greater solubility 
of methoxyflurane is a reflection of a larger 
number of sites to which it can be distributed in the 
erythrocyte membrane. These distinct en- 
vironments are sufficiently different that they give 
rise to unique “F chemical shifts. Chemical ex- 
change between these environments must be slow 
on the NMR time scale, in order that multiple 
peaks be observed. In contrast, the single line 
observed for halothane is consistent with either 
fast exchange among several sites or with a single 
site. In both cases the “F chemical shift reflects the 
environment of the anesthetic in the membrane, 
and the characteristic composition [14] of lipids 
and proteins in the erythrocyte membrane is the 
source of species specificity. We regard the 
chemical shift of the anesthetic as an index to 
characterize that average environment. 
The characteristic differences in line widths for 
anesthetics in plasma (<20 Hz) and in membrane 
(60-200 Hz) reflect differences in mobility at these 
sites. In general, lower mobility will result in 
broader lines. 
We now turn to regularities in the “F chemical 
shifts. Halothane shows a consistent downfield 
shift of fluorine resonance relative to the value in 
water (2.85 ppm). These downfield chemical shifts 
may indicate protein-anesthetic interactions, since 
fluorine-containing amino acids incorporated into 
proteins have been reported to show a wide range 
of signals downfield from their chemical shifts free 
in solution [ 15,161. Methoxyflurane “F signals are 
distributed both down- and upfield from the signal 
observed (-7.03 ppm) for this compound in 
water. The additional upfield peaks not observed 
with halothane may be indicative of interactions 
with the lipid portions of the erythrocyte 
membrane. 
Further systematic studies are required to assign 
the environments occupied by the anesthetics on 
the basis of their “F chemical shift and other NMR 
parameters. Erythrocytes provide a more tractable 
system to work with since their membrane com- 
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position can easily be ma~pulated to aid in the 
spectral assignment. The spectra of halothane in 
nerve show that anesthetic exists at multiple sites 
and that those sites depend on maintenance of 
metabolic activity. Whether one or more of these 
sites is critical for neural activity will be a point to 
investigate in future research. The NMR technique 
potentially can contribute to elucidation of the 
mechanism of anesthesia. 
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